Item 2.02 Results of Operations and Financial Conditions.
On August 14, 2012, Arrhythmia Research Technology, Inc. (the "Company") announced its financial results for the three months and the six months ended June 30, 2012. The full text of the press release issued in connection with the announcement is furnished as Exhibit 99.01 to this Current Report on Form 8-K. The information in this Form 8-K and Exhibit 99.01 attached hereto shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.

Item 9.01 Financial Statements and Exhibits.
(d) Exhibits. Exhibit No. Description
99.01 Press Release dated August 14, 2012.

---